In line with this, exogenous expression of the ECM-modifying enzyme heparanase can increase the tumor infiltration of chimeric-antigen receptor (CAR)–expressing αβ T cells, promoting tumor rejection in melanoma and neuroblastoma xenograft models (21). Here, HPSE is linked to neuroblastoma.